SoftOx Solutions AS will hold its Annual General Meeting on 27th June 2025 at 10 am(CEST). The notice convening the General Meeting, including the agenda and the board's proposals for the matters to be dealt with, is enclosed with this notification and will be sent to all shareholders. Relevant documents referred to in the notice are also made available at https://soft-ox.com/stock-market-announcements/
For further information, please contact:
Ulrik Spork, COB Soft Solutions AS, +45 31 38 83 87
Ingrid Juven, CFO SoftOx Solutions AS, +47 918 76 165
Mail: ir@soft-ox.com
About SoftOx Solutions AS:
SoftOx Solutions AS (ticker: SOFTX) is a clinical-stage pharmaceutical company listed on Euronext Growth Oslo. The company is developing highly effective pan-antimicrobial pharmaceuticals targeting bacteria, viruses, and fungi. The technology is based on extensive research and development in partnership with leading Nordic research institutes.
This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.